99.94
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$100.30
Aprire:
$99.99
Volume 24 ore:
10.19M
Relative Volume:
0.77
Capitalizzazione di mercato:
$247.95B
Reddito:
$63.90B
Utile/perdita netta:
$19.05B
Rapporto P/E:
13.22
EPS:
7.5596
Flusso di cassa netto:
$13.05B
1 W Prestazione:
+0.98%
1M Prestazione:
+7.51%
6M Prestazione:
+22.26%
1 anno Prestazione:
-2.06%
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Confronta MRK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
MRK
Merck Co Inc
|
99.90 | 248.95B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
1,059.38 | 919.64B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
214.37 | 509.76B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
226.88 | 394.69B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
134.44 | 254.37B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-10-13 | Ripresa | Citigroup | Neutral |
| 2025-09-17 | Downgrade | Berenberg | Buy → Hold |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-08 | Downgrade | Truist | Buy → Hold |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-12-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-11 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
Gilead's Experimental Combo Tablet For HIV Treatment Hits Primary Goal - Benzinga
Merck & Co's Options: A Look at What the Big Money is Thinking - Benzinga
Valeo Financial Advisors LLC Reduces Stock Position in Merck & Co., Inc. $MRK - MarketBeat
V. M. Manning & CO. Inc. Invests $1.17 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Bank of America Analyst Says - MarketBeat
Neville Rodie & Shaw Inc. Trims Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Texas Permanent School Fund Corp - MarketBeat
Stance Capital LLC Invests $1.26 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Kestra Investment Management LLC - MarketBeat
Rep. Julie Johnson Sells Off Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Cullen Capital Management LLC Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Corient Private Wealth LLC - MarketBeat
Merck stock (MRK): News, dividend date, Keytruda updates and analyst forecasts to watch before the U.S. market opens Dec. 15, 2025 - ts2.tech
MASTERINVEST Kapitalanlage GmbH Invests $2.92 Million in Merck & Co., Inc. $MRK - MarketBeat
Sterile Bioprocess Filtration Market to Hit USD 21.20 Billion by 2032, Driven by Rising Biologics Production and Adoption of Single Use Filtration Technologies - GlobeNewswire Inc.
Immuno-oncology Clinical Trials Market Projected to Reach USD 23.63 Billion by 2032 at a CAGR of 12.37% - GlobeNewswire Inc.
Thrivent Financial for Lutherans Grows Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Kentucky Retirement Systems Lowers Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Thompson Davis & CO. Inc. Invests $1.17 Million in Merck & Co., Inc. $MRK - MarketBeat
North Dallas Bank & Trust Co. Invests $919,000 in Merck & Co., Inc. $MRK - MarketBeat
National Bank of Canada FI Boosts Position in Merck & Co., Inc. $MRK - MarketBeat
Public Sector Pension Investment Board Reduces Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Evergreen Capital Management LLC - MarketBeat
B. Riley Wealth Advisors Inc. Takes Position in Merck & Co., Inc. $MRK - MarketBeat
LM Advisors LLC Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Lazard Asset Management LLC - MarketBeat
Bcwm LLC Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Curi Capital LLC Buys 65,987 Shares of Merck & Co., Inc. $MRK - MarketBeat
Bridgeway Capital Management LLC Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Brevan Howard Capital Management LP Buys Shares of 448,919 Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Lifted by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Benjamin Edwards Inc. Increases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Guggenheim lifts PT on Merck & Co. (MRK) to $122 from $104 - MSN
Bellevue Group AG Sells 203,132 Shares of Merck & Co., Inc. $MRK - MarketBeat
Banque Transatlantique SA Sells 418,552 Shares of Merck & Co., Inc. $MRK - MarketBeat
AQR Capital Management LLC Buys 1,029,454 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.3% After Analyst Upgrade - MarketBeat
Merck (MRK) Stock News Today: Winrevair EU Expansion, Keytruda Patent Headwinds, Analyst Forecasts and What Investors Watch (Dec. 12, 2025) - ts2.tech
Merck & Co (MRK) Analyst Ratings Update: Morgan Stanley Raises P - GuruFocus
Merck & Co., Inc. (NYSE:MRK) Given New $102.00 Price Target at Morgan Stanley - MarketBeat
Morgan Stanley Adjusts Merck & Co. PT to $102 From $100, Maintains Equalweight Rating - marketscreener.com
Merck Receives Positive EU CHMP Opinion For Expanded Use Of WINREVAIR In Adults With Pulmonary Arterial Hypertension - TradingView — Track All Markets
Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension) - Business Wire
Peapack Gladstone Financial Corp Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Ieq Capital LLC Acquires 348,203 Shares of Merck & Co., Inc. $MRK - MarketBeat
HUB Investment Partners LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Sei Investments Co. - MarketBeat
CIBC Asset Management Inc Sells 78,956 Shares of Merck & Co., Inc. $MRK - MarketBeat
Canada Pension Plan Investment Board Has $287.91 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main - MarketBeat
Alliancebernstein L.P. Sells 1,382,219 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):